Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report)’s stock price dropped 2.6% on Tuesday . The stock traded as low as $24.24 and last traded at $24.24. Approximately 37,306 shares changed hands during trading, a decline of 97% from the average daily volume of 1,348,370 shares. The stock had previously closed at $24.88. Analyst Ratings […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the thirteen analysts that are presently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month price target […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 7,720,000 shares, a decrease of 13.0% from the January 15th total of 8,870,000 shares. Based on an average daily volume of 1,550,000 shares, […]
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Earnings Results, Misses Expectations By $0 46 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) had its target price hoisted by analysts at Citigroup from $33.00 to $34.00 in a report released on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the biotechnology company’s stock. Citigroup’s price objective would suggest a potential upside of 8.35% from the stock’s previous close. […]